SOME RELATED FACTORS AND EVALUATING THE RESULTS OF COMBINED BASAL INSULIN ON TYPE 2 DIABETIC PATIENTS WHO FAILURE TREATMENT WITH ORAL ANTIDIABETIC DRUGS AT OUTPATIENT DEPARTMENT, VINH LONG GENERAL HOSPTIAL
Main Article Content
Abstract
Background: Diabetes mellitus (diabetes mellitus) is a chronic medical condition that causes many dangerous complications. Good control of blood glucose and HbA1c levels has an important role in reducing the rate of progression, as well as slowing and reducing the complications of the disease. However, there are many factors that affect to the failure of oral antidiabetic drugs (OADs) during treatment. It is necessary to use basal insulin as soon as diagnosed or when the patient has failed with OADs therapy. Objectives: 1. Determine the incidence and some of the risk factors associated with failure with OADs treatment in patients with type 2 diabetes; 2. Evaluate treatment results by combining basal insulin in patients with type 2 diabetes who fail with OADs treatment at Outpatient Department, Vinh Long General Hospital in 2019-2020. Materials and methods: A cross – sectional study with analysis. A total of 210 diabetic patients admitted Outpatient Department, Vinh Long General Hospital during the study period. Results: from February 2019 to April 2020, We included 210 diabetic patiens: 63.3% male, 36.7% female, median age: 66.46±8.03. Diabetic patients who failure of treatment with oral drugs were 31.9%. After 3 months combined basal insulin, we included 14.9% patients get target treatment and 85.1% patients don’t get target treatment. Conclusion: Using baseline insulin increases the proportion of patients achieving treatment target, Diabetic patients who failure of treatment with oral drugs needs to combine basal insulin early.
Keywords
Diabetic mellitus, basal insulin
Article Details
References
2. Hứa Thành Nhân (2013), Tỉ lệ đạt mục tiêu HbA1c và một số yếu tố liên quan trên bệnh nhân đái tháo đường típ 2 tại một phòng khám chuyên khoa nội tiết, Luận văn tốt nghiệp Bác sĩ Nội trú, Trường Đại học Y Dược Thành phố Hồ Chí Minh, Thành phố Hồ Chí Minh.
3. Phạm Thị Hồng Nhung (2016), Nghiên cứu đặc điểm lâm sàng, cận lâm sàng, thực trạng kiểm soát đường huyết thông qua HbA1c và một số chỉ số khác trên bệnh nhân đái tháo đường típ 2, Luận văn tốt nghiệp Bác sĩ Đa khoa, Trường Đại học Y Dược Cần Thơ, Cần Thơ.
4. Nguyễn Thị Phương Thảo (2018), Đánh giá hiệu quả và tác dụng phụ của liệu pháp điều trị insulin ở bệnh nhân đái tháo đường típ 2, Luận văn tốt nghiệp Bác sĩ Nội trú, Trường Đại học Y Dược Thành phố Hồ Chí Minh, Thành phố Hồ Chí Minh.
5. American Diabetes Association (2015), "Standards of Medical Care in Diabetes—2015: Abridged for Primary Care Providers", Clin Diabetes, 33 (2), pp.97–111.
6. American Diabetes Association (2018), "Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018 American Diabetes Association", Diabetes Care, 41 (Supplement 1), pp.S13-S27.
7. Cho HN, Shaw JE, Et al (2018), "IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045", Diabetes Res Clin Pract, 138, pp.271-281.
8. Eliasson B, Ekström N, Et al (2014), "Metabolic effects of basal or premixed insulin treatment in 5077 insulin-naïve type 2 diabetes patients: Registry-based observational study in clinical practice", Diabetes Ther, 5 (1), pp.243–254.
9. Gordon J, Pockett RD, Et al (2010), "A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study.", Int J Clin Pract, 64 (12), pp.1609-1618.
10. Holman RR, Farmer AF, Et al (2009), "Three-year efficacy of complex insulin regimens in type 2 diabetes", Randomized Controlled Trial, 361 (18), pp.1736-1747.
11. Kayar Y, Ilhan A, Et al (2017), "Relationship between the poor glycemic control and risk factors, life style andcomplications.", Biomedical Research, 28 (4), pp.1581-1586.